CoChat

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

Open access
Tsibulak, Irina, Reiser, Elisabeth, Bogner, Gerhard, Petru, Edgar, Hell-Teutsch, Johanna, Reinthaller, Alexander, Weirather, Cornelia, Weiss, Tatjana, Bozsa, Szabolcs, Puschacher, Barbara, Hall, Mirijam, Hittler, Doris, Hrauda, Katharina, Thell, Elisabeth, Clauss, Sabine, Pozniak, Johanna, Alicke, Sebastian, Gangl, Daniela, Gamperl, Gottfried, Ebner, Christoph, Knoll, Katharina, Leitner, Katharina, Schilcher, Andrea, Schinnerl, Marina, Sigl, Verena, Singer, Christian, Aigmüller, Thomas, Hofstätter, Birgit, Marth, Christian · 2020 · International Journal of Gynecological Cancer
Cited by 176

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: On March 16, 2020, the federal government of Austria declared a nationwide lockdown due to the COVID-19 pandemic. Since the lockdown, screening examinations and routine checkups have been restricted to prevent the spread of the virus and to increase the hospitals' bed capacity across the country. This resulted in a severe decline of patient referrals to the hospitals. OBJECTIVE: To assess the impact of the COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers in Austria. METHODS: Data of 2077 patients from 18 centers in Austria with newly diagnosed gynecological or breast cancer between January and May 2019 and January and May 2020 were collected. Clinical parameters, including symptoms, performance status, co-morbidities, and referral status, were compared between the time before and after the COVID-19 outbreak. RESULTS: Our results showed a slight increase of newly diagnosed cancers in January and February 2020 as compared with 2019 (+2 and +35%, respectively) and a strong decline in newly diagnosed tumors since the lockdown: -24% in March 2020 versus March 2019, -49% in April 2020 versus April 2019, -49% in May 2020 versus May 2019. Two-thirds of patients diagnosed during the pandemic presented with tumor-specific symptoms compared with less than 50% before the pandemic (p<0.001). Moreover, almost 50% of patients in 2020 had no co-morbidities compared with 35% in 2019 (p<0.001). Patients, who already had a malignant disease, were rarely diagnosed with a new cancer in 2020 as compared with 2019 (11% vs 6%; p<0.001). CONCLUSIONS: The lockdown led to a decreased number of newly diagnosed gynecological and breast cancers. The decreased accessibility of the medical services and postponed diagnosis of potentially curable cancers during the COVID-19 pandemic may be a step backwards in our healthcare system and might impair cancer treatment outcomes. Therefore, new strategies to manage early cancer detection are needed to optimize cancer care in a time of pandemic in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ijgc-2020-001975

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Metadata

Authors
Tsibulak, I., Reiser, E., Bogner, G., Petru, E., Hell-Teutsch, J., Reinthaller, A., Weirather, C., Weiss, T., Bozsa, S., Puschacher, B., Hall, M., Hittler, D., Hrauda, K., Thell, E., Clauss, S., Pozniak, J., Alicke, S., Gangl, D., Gamperl, G., Ebner, C., Knoll, K., Leitner, K., Schilcher, A., Schinnerl, M., Sigl, V., Singer, C., Aigmüller, T., Hofstätter, B., & Marth, C.
Venue
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Published
2020-11
Volume
30
Issue
11
Pages
1667-1671
ISSN
1048-891X (ISSN-L)
OpenAlex
W3091970799
Cited by
176
References
2
FWCI
13.55
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective. https://app.cochat.ai/papers/10.1136/ijgc-2020-001975
The paper
Tsibulak, I., Reiser, E., Bogner, G., Petru, E., Hell-Teutsch, J., Reinthaller, A., Weirather, C., Weiss, T., Bozsa, S., Puschacher, B., Hall, M., Hittler, D., Hrauda, K., Thell, E., Clauss, S., Pozniak, J., Alicke, S., Gangl, D., Gamperl, G., . . . Marth, C. (2020). Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective. International Journal of Gynecological Cancer. https://doi.org/10.1136/ijgc-2020-001975

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.